Austin, Texas-based Luminex Corp. has agreed to acquire Milliporesigma's flow cytometry portfolio for $75 million, consisting of about $69.9 million to be paid under a stock and asset purchase agreement and roughly $5.1 million in committed inventory purchases.

The latest med-tech IPO comes from SI-Bone Inc., which managed to price at the high end of its proposed range and upsized the offering. That's despite a turbulent broader market and a slew of other life sciences offerings; these trends could make it difficult to get med-tech IPOs done if they continue. But, med-tech IPOs have been getting bigger and splashier; this is at least the sixth IPO to raise over $100 million in 2018. (See BioWorld MedTech, Oct. 8, 2018.)